Aptar originally developed spray valves and pumps for consumer and household products. Later, the company began producing nasal administration and pulmonary drug delivery devices such as nasal spray systems and metered-dose inhaler valves. Biotech and pharmaceutical companies use Aptar’s different Unidose and Bidose devices for the single or two-shot intranasal delivery of other medicines.
Aptar Pharma is a proud exhibitor and Platinum Sponsor at the 2021 PDA Universe of Pre-Filled Syringes & Injection Devices Conference. The conference will take place online on 5-6 October 2021 at 1330 hrs IST.
As the go-to drug delivery expert, for over 50 years, Aptar Pharma has been providing best-in-class injectable components for Pre-Filled Syringes, Vials, and Auto-Injectors to pharma partners worldwide.
At this year’s conference, visitors to our online booth can meet with our Aptar Pharma experts via video or text chat and discover Aptar Pharma’s wide portfolio of elastomeric components and services to support and fast-track your drug development projects.
Jean-Edouard Rabier, global business development director, Aptar Pharma, and Sebastien Cordier, technical product manager, Aptar Pharma will be the speaker for the topic “PremiumCoat® Platform Vial and PFS Applications” on 5 October 2021.
Audrey Chardonnet, global business development director, and Laure-Hélène Guillemot, project engineer at Aptar Pharma will be the speaker for the topic“PremiumCoat® 1-3 mL Syringe Plunger for Vaccine and Biotech Applications” on 6 October 2021.
The PDA Universe of Pre-Filled Syringes and Injection Devices Conference has been running since 2004 and has become a must-attend event for those working in the biopharmaceutical and parenteral drug delivery and device development fields. This is the second year that the conference will be held virtually. This year’s conference theme will be Collaboration and Simplification to Accelerate Device Development and Drug Delivery.
Aptar Pharma looks forward to welcoming you there.
To register and find out more information, click here.
